- Home
- GLMD vs PMAX Comparison
GLMD vs PMAX Comparison
Compare GLMD & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- PMAX
- Stock Information
- Founded
- GLMD 2000
- PMAX 2019
- Country
- GLMD Israel
- PMAX Hong Kong
- Employees
- GLMD N/A
- PMAX N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- PMAX
- Sector
- GLMD Health Care
- PMAX
- Exchange
- GLMD Nasdaq
- PMAX Nasdaq
- Market Cap
- GLMD 7.5M
- PMAX 6.7M
- IPO Year
- GLMD 2014
- PMAX 2024
- Fundamental
- Price
- GLMD $1.48
- PMAX $0.29
- Analyst Decision
- GLMD Hold
- PMAX
- Analyst Count
- GLMD 1
- PMAX 0
- Target Price
- GLMD N/A
- PMAX N/A
- AVG Volume (30 Days)
- GLMD 213.6K
- PMAX 2.1M
- Earning Date
- GLMD 11-13-2025
- PMAX 10-17-2025
- Dividend Yield
- GLMD N/A
- PMAX N/A
- EPS Growth
- GLMD N/A
- PMAX N/A
- EPS
- GLMD N/A
- PMAX N/A
- Revenue
- GLMD N/A
- PMAX $4,694,079.00
- Revenue This Year
- GLMD N/A
- PMAX N/A
- Revenue Next Year
- GLMD N/A
- PMAX N/A
- P/E Ratio
- GLMD N/A
- PMAX N/A
- Revenue Growth
- GLMD N/A
- PMAX N/A
- 52 Week Low
- GLMD $1.15
- PMAX $0.23
- 52 Week High
- GLMD $23.80
- PMAX $4.60
- Technical
- Relative Strength Index (RSI)
- GLMD 51.13
- PMAX 42.68
- Support Level
- GLMD $1.33
- PMAX $0.29
- Resistance Level
- GLMD $1.60
- PMAX $0.33
- Average True Range (ATR)
- GLMD 0.10
- PMAX 0.04
- MACD
- GLMD 0.03
- PMAX 0.00
- Stochastic Oscillator
- GLMD 66.67
- PMAX 26.73
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.